Advertisement
Advertisement

HCAT

HCAT logo

Health Catalyst, Inc Common Stock

2.15
USD
Sponsored
-0.01
-0.37%
Jan 30, 16:00 UTC -5
Closed
exchange

After-Market

2.15

0.00
+0.14%

HCAT Earnings Reports

Positive Surprise Ratio

HCAT beat 23 of 26 last estimates.

88%

Next Report

Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$75.46M
/
$0.09
Implied change from Q3 25 (Revenue/ EPS)
-1.13%
/
+50.00%
Implied change from Q4 24 (Revenue/ EPS)
-5.20%
/
+125.00%

Health Catalyst, Inc Common Stock earnings per share and revenue

On Nov 10, 2025, HCAT reported earnings of 0.06 USD per share (EPS) for Q3 25, missing the estimate of 0.06 USD, resulting in a -0.66% surprise. Revenue reached 76.32 million, compared to an expected 77.42 million, with a -1.41% difference. The market reacted with a -5.61% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analysts forecast an EPS of 0.09 USD, with revenue projected to reach 75.46 million USD, implying an increase of 50.00% EPS, and decrease of -1.13% in Revenue from the last quarter.
FAQ
For Q3 2025, Health Catalyst, Inc Common Stock reported EPS of $0.06, missing estimates by -0.66%, and revenue of $76.32M, -1.41% below expectations.
The stock price moved down -5.61%, changed from $2.85 before the earnings release to $2.69 the day after.
The next earning report is scheduled for Feb 24, 2026.
Based on 12 analysts, Health Catalyst, Inc Common Stock is expected to report EPS of $0.09 and revenue of $75.46M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement